Zentek Ltd. (NASDAQ:ZTEK) Short Interest Down 27.5% in August

Key Points

• Zentek Ltd. experienced a 27.5% decline in short interest in August, with the total short interest falling from 119,800 shares to 86,800 shares.
• The company's shares have seen significant fluctuations, with a 1-year low of $0.50 and a high of $1.84, currently trading at $0.95.
• For the latest quarter, Zentek reported a negative net margin of 981.17% and revenue of $0.04 million.

Zentek Ltd. (NASDAQ:ZTEK - Get Free Report) was the recipient of a large drop in short interest in August. As of August 31st, there was short interest totaling 86,800 shares, a drop of 27.5% from the August 15th total of 119,800 shares. Based on an average trading volume of 281,000 shares, the short-interest ratio is currently 0.3 days. Currently, 0.1% of the company's shares are sold short. Currently, 0.1% of the company's shares are sold short. Based on an average trading volume of 281,000 shares, the short-interest ratio is currently 0.3 days.

Zentek Trading Up 0.6%

Shares of ZTEK stock traded up $0.01 during mid-day trading on Friday, hitting $0.94. The company's stock had a trading volume of 60,868 shares, compared to its average volume of 839,136. The company's fifty day simple moving average is $0.85 and its 200-day simple moving average is $1.13. Zentek has a 52 week low of $0.50 and a 52 week high of $1.84. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.30 and a current ratio of 1.62. The company has a market cap of $98.08 million, a PE ratio of -18.73 and a beta of 0.59.

Zentek (NASDAQ:ZTEK - Get Free Report) last issued its earnings results on Thursday, August 14th. The company reported ($0.01) EPS for the quarter. Zentek had a negative net margin of 981.17% and a negative return on equity of 55.41%. The firm had revenue of $0.04 million during the quarter.

Zentek Company Profile

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.